Christine Baeder Discusses the Future of the Biosimilar Industry, Insulins
April 9th 2023
By Justina Petrullo
VideoUpon coming into her position as the new chair of the Association for Accessible Medicines (AAM), Christine Baeder discussed what she believes the future holds for biosimilars, good and bad, and the questions that still surround the insulin price cap.